These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 19205386

  • 1. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency].
    Hyla-Klekot L, Grenda R, Pulcer B.
    Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386
    [Abstract] [Full Text] [Related]

  • 2. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis.
    Sozeri B, Mir S, Mutlubas F, Sen S.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):87-92. PubMed ID: 20061699
    [Abstract] [Full Text] [Related]

  • 3. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [Abstract] [Full Text] [Related]

  • 4. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 5. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009 Nov; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 6. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.
    Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947
    [Abstract] [Full Text] [Related]

  • 7. Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome.
    Ulinski T.
    Curr Opin Organ Transplant; 2010 Oct 15; 15(5):628-32. PubMed ID: 20733489
    [Abstract] [Full Text] [Related]

  • 8. Glomerular podocyte vacuolation in focal segmental glomerulosclerosis.
    Yoshikawa N, Ito H, Akamatsu R, Hazikano H, Okada S, Matsuo T.
    Arch Pathol Lab Med; 1986 May 15; 110(5):394-8. PubMed ID: 3754422
    [Abstract] [Full Text] [Related]

  • 9. Focal segmental glomerulosclerosis, crescent, and rapidly progressive renal failure.
    Ramirez F, Travis LB, Cunningham RJ, Cavallo T, Rajarman S, Brouhard BH, Ellis EN.
    Int J Pediatr Nephrol; 1982 Sep 15; 3(3):175-8. PubMed ID: 7141789
    [Abstract] [Full Text] [Related]

  • 10. [Current aspects of transformation of morphological changes in children with nephrotic syndrome depending on the treatment regimen].
    Sharipov AM, Khamzaeva KA.
    Urologiia; 2007 Sep 15; (2):68-71. PubMed ID: 17580388
    [Abstract] [Full Text] [Related]

  • 11. Development of renal insufficiency after long-standing steroid-responsive nephrotic syndrome.
    Trainin EB, Gomez-Leon G.
    Int J Pediatr Nephrol; 1982 Jun 15; 3(2):55-8. PubMed ID: 7107119
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH, Fisher M, Neale TJ.
    N Z Med J; 1990 Mar 28; 103(886):125-6. PubMed ID: 2320338
    [Abstract] [Full Text] [Related]

  • 13. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
    Kari JA, Halawani M, Mokhtar G, Jalalah SM, Anshasi W.
    Saudi J Kidney Dis Transpl; 2009 Sep 28; 20(5):854-7. PubMed ID: 19736491
    [Abstract] [Full Text] [Related]

  • 14. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
    Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G.
    Am J Kidney Dis; 2003 Feb 28; 41(2):328-35. PubMed ID: 12552493
    [Abstract] [Full Text] [Related]

  • 15. FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy.
    De Smet E, Rioux JP, Ammann H, Déziel C, Quérin S.
    Nephrol Dial Transplant; 2009 Sep 28; 24(9):2938-40. PubMed ID: 19509024
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY.
    Transpl Int; 2007 Jan 28; 20(1):102-5. PubMed ID: 17181660
    [Abstract] [Full Text] [Related]

  • 17. [Nephrotic syndrome in childhood].
    Reusz G, Szabó A, Fekete A.
    Orv Hetil; 2006 Nov 26; 147(47):2251-60. PubMed ID: 17380687
    [Abstract] [Full Text] [Related]

  • 18. A male patient with steroid-dependent nephrotic syndrome for 25 years and obesity-associated focal segmental glomerulosclerosis.
    Motoyama O, Muto A, Ogiwara H, Mizuiri S, Kawamura S, Iitaka K.
    Clin Exp Nephrol; 2004 Sep 26; 8(3):263-5. PubMed ID: 15480905
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 20. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
    Han KH, Kim SH.
    Biomed Res Int; 2016 Jul 15; 2016():3053706. PubMed ID: 27195285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.